Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q3 2024 to Q4 2024
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 4
- Est. +$19.4M
- Added
- 35
- Est. +$41.6M
- Reduced
- 25
- Est. −$36.8M
- Sold out
- 7
- Est. −$12.7M
Portfolio value went from $212.0M to $215.0M (+$2.98M (+1.4%)); positions from 67 to 64 (−3).
All Q4 2024 holdingsAll Q3 2024 holdings
In the shares, value and % of portfolio columns, the top figure is Q4 2024 and the gray one below is Q3 2024. For stocks that split between the two quarters, Q3 2024 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| ITOSiTeos Therapeutics, Inc. | NewHistory | 11,0610 | +11,061 | $84.9K$0 | +$84.9K | <0.1%0.0% | +0.04 |
| ProShares Tr74347R107 | New– | 4,0420 | +4,042 | $374.0K$0 | +$374.0K | 0.2%0.0% | +0.17 |
| SPDR Series Trust78468R796 | New– | 124,2270 | +124,227 | $5.98M$0 | +$5.98M | 2.8%0.0% | +2.78 |
| iShares Tr464289883 | New– | 347,2770 | +347,277 | $13.0M$0 | +$13.0M | 6.0%0.0% | +6.02 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.